OFF-THE-SHELF INVARIANT NATURAL KILLER T CELL IMMUNOTHERAPY IS FEASIBLE, SAFE AND PROMOTES REGULATORY AND CYTOTOXIC HOST IMMUNE CELLS IN THE DOG

(for more details consult abstract)

EXPANSION OF PHENOTYPICALLY SENESCENT CD57+ CD8 T CELLS IS ASSOCIATED WITH IMPAIRED IMMUNOCOMPETENCE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

(for more details consult abstract)

MULTISTATE ANALYSIS OF ALLOGENEIC HSCT IN PATIENTS ≥ 70 YEARS COMPARED TO POPULATION MORTALITY BASED ON THE GERMAN REGISTRY FOR STEM CELL TRANSPLANTATION (DRST)

(for more details consult abstract)

A PHASE 1/2A STUDY OF DECIDUAL STROMAL CELLS FOR THE TREATMENT OF COVID-19 ARDS.

(for more details consult abstract)

THE IMPACT OF DONOR-SPECIFIC ANTIBODIES PRESENCE ON THE OUTCOME POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTION: A SURVEY FROM A SINGLE CENTER.

(for more details consult abstract)

UM171 EXPANSION OF SMALL CORD BLOODS PROVIDES ACCESS TO SAFE TRANSPLANTATION FOR DONORLESS PATIENTS WITH EXCELLENT LONGTERM FOLLOW-UP

(for more details consult abstract)

GRAFT ENGINEERING: HOW LONG CAN YOU WAIT, HOW LOW CAN YOU GO, AND PANDEMIC READINESS

(for more details consult abstract)

MECHANISMS OF T CELL TOLERANCE AFTER PT-CY HAPLOTRANSPLANTATION

(for more details consult abstract)